Management of scleral melt

Bennett E. Ahearn, Kathryn E. Lewis, Blair E. Reynolds, Ahmad Kheirkhah

Research output: Contribution to journalReview articlepeer-review


Scleral melting, while rare, can lead to significant ocular morbidity. Several possible risk factors for scleral melt have been identified, such as infection, autoimmune disease, trauma, and post-surgical state, and these may act in combination with each other. Treatment should be tailored according to the etiology and severity of the scleral melt. Medical management may be indicated, especially in cases of autoimmune-related melt; however, surgical procedures are often necessary due to compromised ocular integrity and limited penetration of medications into the avascular sclera. An understanding of the surgical options available and their operative outcomes is particularly important when choosing the appropriate treatment protocol for each patient.

Original languageEnglish (US)
Pages (from-to)92-99
Number of pages8
JournalOcular Surface
StatePublished - Jan 2023


  • Scleral enforcement
  • Scleral graft
  • Scleral melt
  • Scleral necrosis

ASJC Scopus subject areas

  • Ophthalmology


Dive into the research topics of 'Management of scleral melt'. Together they form a unique fingerprint.

Cite this